Pfizer (PFE) CEO Isn't Ready For A Fight With RFK Jr., Says Jim Cramer
Pharma giant Pfizer Inc. (NYSE:PFE)’s shares are down by 4.7% over the past year and flat year-to-date.
Pfizer Inc (PFE)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Hourglass Capital Kenneth A. Moffet | 438,148 | $10,909,885 | -7% | 2.35% |
| 2. | Beech Hill Partners Paul Cantor, Joseph Weiss, And Will Wurm | 70,627 | $1,758,612 | -2% | 0.84% |
| 3. | Bourgeon Capital John Zaro | 13,271 | $330,448 | 0.05% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $25.65 | 19,457 | $499,072.05 | 27,707 | 2025-02-13 | Filing | |
| $28.24 | 1,000 | $28,240.00 | 10,000 | 2024-10-30 | Filing | |
| $26.47 | 3,000 | $79,401.00 | 9,000 | 2023-12-15 | Filing | |
| $38.58 | 1,000 | $38,580.00 | 6,000 | 2023-05-08 | Filing | |
| $38.43 | 1,000 | $38,425.00 | 5,000 | 2023-05-05 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $25.93 | 2,500 | $64,825.00 | 11,850 | 2025-03-04 | Filing | |
| $28.66 | 5,154 | $147,713.64 | 8,582 | 2024-08-13 | Filing | |
| $40.02 | 9,912 | $396,678.24 | 9,003 | 2023-03-15 | Filing | |
| $53.96 | 4,218 | $227,603.28 | 10,846 | 2022-06-07 | Filing | |
| $50.50 | 4,000 | $202,000.00 | 15,064 | 2022-05-16 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 55,873,002 | $1,391,237,751 | 0.45% | |
| 2. | 15,131,451 | $376,773,130 | 0.22% | |
| 3. | 9,870,643 | $245,779,014 | 0.35% | |
| 4. | 5,205,453 | $129,615,780 | 0.2% | |
| 5. | 4,823,166 | $120,072,718 | 0.1% |
News See All
Why Pfizer Inc. (PFE) is One of the Best Affordable Stocks Under $30
Pfizer Inc. (NYSE:PFE) is one of the best affordable stocks under $30. Pfizer Inc.
10 Stocks Jim Cramer Talked About
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer discussed the impact of the Justice Department serving the Federal Reserve with grand jury subpoenas and threatening criminal indictment...
10 Best Affordable Stocks Under $30
According to her, the earnings engine in the United States is on, with analysts expecting 8% earnings growth this quarter, making the bar “pretty manageable”.
UBS Likes Pfizer’s MTSR Obesity Deal but Stays Neutral on PFE
On January 7, UBS initiated coverage of Pfizer Inc. (NYSE:PFE) with a Neutral rating and a $25 price target.
13 Best Dividend Stocks Paying Over 6%
Dividend yield has always been a point of debate in the market. Many investors are naturally drawn to high yields, seeing them as an easy way to generate income.
Pfizer, Astellas Report Positive Phase 3 Trial Results for PADCEV Combination in Bladder Cancer Treatment
Pfizer Inc. (NYSE:PFE) is one of the most buzzing stocks to invest in according to hedge funds. Earlier on December 17, Astellas Pharma and Pfizer Inc.
14 Most Buzzing Stocks to Invest In According to Hedge Funds
On January 1, Ryan Detrick of Carson Group appeared on CNBC's 'Closing Bell Overtime' to talk about his bullish outlook for 2026.
Pfizer (PFE) Plans Price Increases on About 80 Medicines Despite Broader Pricing Deals
Pfizer Inc. (NYSE:PFE) is among the drugmakers planning to raise prices on some medicines starting January 1.
13 Best January Dividend Stocks to Invest In
Valuations have climbed to historically high levels as tech stocks stayed in favor.
Hedge Fund Resource Center Billionaire Hedge Funds
